The explosive rise of drugs like Ozempic and Mounjaro is shifting consumption patterns, health outcomes and pushing pharmaceutical giants into trillion-dollar valuations.

Nov 21 (Reuters) - Eli Lilly (LLY.N), opens new tab hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its ...

CNBC's Annika Kim Constantino reports on news regarding Eli Lilly. Judge Delivers Final Blow to Trump Case 'Total exoneration'? Secrecy experts weigh in on Hegseth's Signal flap What is ‘scromiting’ ...

An experimental medication was shown to help boost weight loss by up to 20%, a study found. Eloralintide, a once-weekly injectable manufactured by Eli Lilly in Indianapolis, led to "meaningful, ...

Eli Lilly has crossed a threshold that once seemed reserved for consumer tech giants, becoming the first pharmaceutical ...

James Corden admitted he ditched Ozempic last year after it failed to curb his eating habits - but his lookalike sister, Ruth ...

US stock futures trimmed losses as dip buyers stepped in after concerns over Oracle Corp.’s plans for vast capital outlays on ...

Buyers emerged for US stocks after concerns on Oracle Corp.’s plans for vast capital outlays on artificial-intelligence infrastructure drove a broad retreat from risky assets.

Eli Lilly said its next generation weight-loss drug retatrutide resulted in significant weight loss and reduced knee pain in ...

Eli Lilly's experimental drug, retatrutide, showed strong results in a late-stage trial, helping patients lose nearly 29% of ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

Eli Lilly has unveiled a new weight loss drug that appears to be delivering the highest weight loss yet in clinical trials ...